New plant to strengthen GC’s dental pharmaceutical business

The new three-storey facility is planned to have a total floor area of 5,358 m². Its design and construction have been commissioned to Chiyoda TechnoAce, a company with a long history of and experience in building of medical product manufacturing plants, GC announced.

In line with GC’s global Communication Loop concept, a commitment to improving communication and the exchange of knowledge among employees, the new facility will be designed with open spaces that aim to foster interaction. “Inspiration is born where people are engaged in conversation, and within the space of a creative setting, shared experiences and emotions help to promote mutual understanding. GC sees a large amount of new power emanating from this understanding,” commented the company on its philosophy.

Showa Yakuhin Kako is one of Japan’s leading dental pharmaceutical manufacturers and known for its range of local anaesthetics and medication for treating periodontal disease. Building on the synergistic effects of combining both companies’ respective fields of expertise, the new facility is part of GC’s efforts to achieve its goal for its 100^th anniversary in 2021: to become the top dental company in the world through making further contributions towards a healthy, long-living society.

Tags: